Skip to main content

Advertisement

Table 2 Echocardiographic variables for control and diabetic groups after 10 days of induction

From: Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats

Variables Control group (n = 4) Diabetic group (n = 4) P value
Left atrium dimension (mm) 2.8 ± 0.3 3.0 ± 0.7 NS
Interventricular septum thickness (mm) 1.9 ± 0.2 1.9 ± 0.3 NS
Posterior wall thickness (mm) 1.8 ± 0.2 1.8 ± 0.4 NS
LV end-diastolic dimension (mm) 5.3 ± 0.1 5.0 ± 0.1 NS
LV end-systolic dimension (mm) 2.8 ± 0.1 3.1 ± 0.1 NS
LV fractional shortening 0.48 ± 0.1 0.37 ± 0.2 NS
LV mass index (g/body weight) 2.4 ± 0.5 2.1 ± 0.2 NS
Isovolumic relaxation time (ms) 28 ± 2 59 ± 9 < 0.001
E peak velocity (cm/s) 80 ± 10 50 ± 14 < 0.05
S' peak velocity (cm/s) 3.8 ± 0.5 2.5 ± 0.5 < 0.05
E/E' 13 ± 2 14 ± 5 NS
  1. LV = left ventricular; S' = systolic septal mitral annulus peak velocity.
  2. t test, NS = nonsignificant; P < 0.05.